NewsHealth

Actions

Blood pressure medicine recalled due to nitrosamine levels

meds.jpg
Posted at 1:50 PM, Mar 22, 2022
and last updated 2022-03-22 13:50:09-04

Pfizer has voluntarily recalled some blood pressure medicines due to nitrosamine levels.

The company said it is recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril and hydrochlorothiazide and quinapril HCl/ hydrochlorothiazide) to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake (ADI) level. Pfizer will recall six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets and four lots of quinapril HCl/ hydrochlorothiazide tablets.

Pfizer added, "Nitrosamines are common in water and foods, including cured and grilled meats, dairy products and vegetables. Everyone is exposed to some level of nitrosamines. These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time."

The products that are being recalled treat hypertension.

Below are images of the recalled items and more information follows.

p.PNG
Recalled items
p1.PNG

Phfizer said, Patients who are taking this product should consult with their healthcare provider or pharmacy to determine if they have the affected product. Patients with the affected product should contact Sedgwick at 888-843-0247 (Mon.-Fri. 8:00 am - 5:00 pm ET) for instructions on how to return their product and obtain reimbursement for their cost.

Click here to read more from Pfizer